Trastuzumab emtansine vs lapatinib and capecitabine in HER2-positive metastatic breast cancer brain metastases: A real-world study

por Sanglier, Thibaut, Shim, Jinjoo, Lamarre, Neil, Peña-Murillo, Claudia, Antao, Vincent, Montemurro, Filippo
Publicado 2023

T-DM1 after Pertuzumab plus Trastuzumab: Treatment Sequence-Induced Selection Bias in HER2-Positive Metastatic Breast Cancer

por Sanglier, Thibaut, Fabi, Alessandra, Flores, Carlos, Flahavan, Evelyn M., Pena-Murillo, Claudia, Meyer, Anne-Marie, Montemurro, Filippo
Publicado 2022